Results 111 to 120 of about 7,739 (166)

Refractory inappropriate sinus tachycardia treated with hybrid ablation. [PDF]

Br J Cardiol
Laird M, Foley P.
europepmc   +1 more source

A scoping review of the evidence supporting antiarrhythmic use after paediatric cardiac surgery. [PDF]

Cardiol Young
Sullenger RD, Kohlmann T, Kilborn AG, Commander SJ, Foote HP, Zimmerman KO, Hill KD, Hornik C, Thompson EJ.   +8 more
europepmc   +1 more source

Potential use of ivabradine in postoperative junctional ectopic tachycardia: a systematic review and single-arm meta-analysis. [PDF]

BMC Cardiovasc Disord
Balweel H, Immanuel SS, Budiono J, Cusan C, Gotama JE, Tafriend NA, Harsoyo A.   +6 more
europepmc   +1 more source

Maximizing treatment response in patients with neuropathic-subtype postural orthostatic tachycardia syndrome. [PDF]

Front Neurol
Rilinger RG, Chin AY, Cantrell C, Levine M, Stallkamp Tidd SJ, Wilson R.   +5 more
europepmc   +1 more source

Personalized management of angina and heart failure in clinical practice in the Middle East: a narrative review. [PDF]

J Comp Eff Res
Ali JA, Mittal B, Deeb FE, Semaan C, Sabbour HM.   +4 more
europepmc   +1 more source

Rethinking heart rate modulation in heart failure: physiological basis, clinical evidence, and individualized targets: a narrative review. [PDF]

Cardiovasc Diagn Ther
Yumita Y, Nagatomo Y, Kawai A, Iwashita M, Mizutani K, Naito A, Chishiki T, Ikegami Y, Adachi T.   +8 more
europepmc   +1 more source

Effect of heart rate reduction with ivabradine on quality of life in advanced cancer patients. [PDF]

ESC Heart Fail
Bewarder Y, Zimmer A, Anker M, Anker S, Christofyllakis K, Bewarder M, Schwantke I, Böhm M.   +7 more
europepmc   +1 more source

Effects of sacubitril/valsartan combined with ivabradine in treating cardiorenal syndrome. [PDF]

Am J Transl Res
Li G, Liu H, Zhou S, Xiong W.
europepmc   +1 more source

Cardiac drug potential: exploring individual and combined cardiac drugs to promote differentiation of adipose-derived stem cells into cardiomyocytes. [PDF]

Mol Biol Rep
Alshammari H, Abuhaimed J, Alshehri S, Siyal A, Shaheen S, Al-Saud SA.   +5 more
europepmc   +1 more source

The Hyperpolarization-Activated, Cyclic-Nucleotide (HCN) Ion Channel Inhibitors as Potential Therapy for Pain, CNS Disorders, Psychiatric Disorders, and Tinnitus. [PDF]

ACS Med Chem Lett
Abdel-Magid AF.
europepmc   +1 more source